Evidence map›Paper›PMID 37487561›Full record

ArticleThe American journal of tropical medicine and hygiene2023

Case Report: Extensive Facial Cutaneous Leishmaniasis in a Neonate.

Sapir Itzhaki Gabay, Yuliya Valdman-Grinshpoun, Galina Ling, Shalom Ben-Shimol, Gidon Test, Or Kaplan, Amir Horev

Open access · greenAbstract readCase Reports
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sapir Itzhaki GabayDepartment of Dermatology, Soroka University Medical Center, Beer-Sheva, Israel.
Yuliya Valdman-GrinshpounDepartment of Dermatology, Soroka University Medical Center, Beer-Sheva, Israel.
Galina LingFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Shalom Ben-ShimolFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Gidon TestPediatric Emergency Department, Soroka University Medical Center, Beer-Sheva, Israel.
Or KaplanPediatric Emergency Department, Soroka University Medical Center, Beer-Sheva, Israel.
Amir HorevFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Soroka Medical Center · ILBen-Gurion University of the Negev · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) is a skin infection caused by various species of the Leishmania parasite and is spread by the bite of an infected female sandfly. In southern Israel, CL caused by Leishmania major is endemic. Cutaneous leishmaniasis is considered a self-limiting disease, characterized by progressive, long-lasting nodulo-ulcerative skin lesions, which usually resolve in several months to years, and leads to scarring, cosmetic disfigurement, and future stigmatization. Although CL is a common disease among children, reports of CL in children younger than 1 year are rare. We present a case of extensive facial CL in an infant whose initial lesions appeared only 25 days after birth. The patient was treated with intravenous liposomal amphotericin B. Two months later, marked improvement was seen, with complete resolution of the inflammation and atrophic scar formation. To our knowledge, this is the earliest age of CL published to date.

Indexed as

Antiprotozoal AgentsLeishmania majorLeishmaniasis, CutaneousLeishmania tropicaChildFemaleHumansInfantInfant, NewbornInflammationAntiprotozoal Agents

Identifiers

PMID37487561
PMCPMC10484260
OpenAlexW4385197224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.